Phase II trial of docetaxel in patients with recurrent malignant glioma: a study of the National Cancer Institute of Canada Clinical Trials Group
Year: 1996
Type: article
Study design: Clinical Trial
Source: Investigational New Drugs
DOI: 10.1007/bf00210791
Authors: Peter Forsyth, Greg Cairncross, David Stewart, Michael Goodyear, Nancy Wainman, Elisabeth Eisenhauer
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W1973725909
